DK0520406T3 - Diastereomert salt af optisk aktiv quinolinmevalonsyre - Google Patents

Diastereomert salt af optisk aktiv quinolinmevalonsyre

Info

Publication number
DK0520406T3
DK0520406T3 DK92110636T DK92110636T DK0520406T3 DK 0520406 T3 DK0520406 T3 DK 0520406T3 DK 92110636 T DK92110636 T DK 92110636T DK 92110636 T DK92110636 T DK 92110636T DK 0520406 T3 DK0520406 T3 DK 0520406T3
Authority
DK
Denmark
Prior art keywords
optically active
diastereomeric salt
mevalonic acid
active quinoline
quinoline
Prior art date
Application number
DK92110636T
Other languages
Danish (da)
English (en)
Inventor
Yoshio Ohara
Mikio Suzuki
Yoshinobu Yanagawa
Hiroshi Iwasaki
Nobuhide Miyachi
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Application granted granted Critical
Publication of DK0520406T3 publication Critical patent/DK0520406T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK92110636T 1991-06-24 1992-06-24 Diastereomert salt af optisk aktiv quinolinmevalonsyre DK0520406T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15181091 1991-06-24
JP12727792A JP3528186B2 (ja) 1991-06-24 1992-05-20 光学活性キノリンメバロン酸のジアステレオマー塩

Publications (1)

Publication Number Publication Date
DK0520406T3 true DK0520406T3 (da) 1998-12-14

Family

ID=26463266

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92110636T DK0520406T3 (da) 1991-06-24 1992-06-24 Diastereomert salt af optisk aktiv quinolinmevalonsyre

Country Status (10)

Country Link
US (3) US5284953A (cs)
EP (2) EP0520406B1 (cs)
JP (1) JP3528186B2 (cs)
KR (1) KR100208867B1 (cs)
AT (1) ATE170513T1 (cs)
CA (1) CA2072162C (cs)
DE (1) DE69226822T2 (cs)
DK (1) DK0520406T3 (cs)
ES (1) ES2120973T3 (cs)
TW (1) TW293007B (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69526784T2 (de) * 1994-02-25 2002-09-05 Daicel Chemical Industries, Ltd. Verfahren zur herstellung von optisch aktiven mevalonolactonen
NZ312907A (en) 1995-07-17 2000-12-22 Warner Lambert Co Crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl
UA29513C2 (uk) * 1995-12-22 2000-11-15 Кова Компані, Лтд Фармацевтична композиція, що включає (е)-3,5-дигідрокси-7-[4'-4''-фторфеніл-2'-циклопропілхінолін-3'-іл]-6- гептенову кислоту
GB9614804D0 (en) * 1996-07-15 1996-09-04 Chiroscience Ltd Resolution process
BR9813760A (pt) 1997-12-19 2000-10-03 Warner Lambert Export Limited Processo para a sìntese de 1,3-dióis
WO2000005213A1 (en) 1998-07-23 2000-02-03 Nissan Chemical Industries, Ltd. Process for the preparation of quinoline derivative and intermediate therefor
KR100311645B1 (ko) * 1999-12-24 2001-10-12 이홍천 간판
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
DE60239793D1 (de) * 2001-04-05 2011-06-01 Nissan Chemical Ind Ltd Verfahren zur herstellung von 7-chinolinyl-3,5-dihydroxyhept-6-enoat
JP4783998B2 (ja) * 2001-05-15 2011-09-28 宇部興産株式会社 (3r,5s)−7−置換−3,5−ジヒドロキシヘプト−6−エン酸の製法
WO2003027073A1 (fr) * 2001-09-19 2003-04-03 Ube Industries, Ltd. Procede de production d'ester optiquement actif d'acide 7-{2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl}-3,5-dihydroxyhept-6-enoique
US6835838B2 (en) * 2002-01-28 2004-12-28 Novartis Ag Process for the manufacture of organic compounds
WO2003064392A1 (en) 2002-01-31 2003-08-07 Novartis Ag Process for the manufacture of hmg-coa reductase inhibitors
DE60334627D1 (de) * 2002-09-20 2010-12-02 Nissan Chemical Ind Ltd Verfahren zur herstellung eines 3,5-dihydroxy-6-heptenoats
EP1592668A1 (en) 2003-02-12 2005-11-09 Ciba SC Holding AG Crystalline forms of pitavastatin calcium
EP1614429A4 (en) * 2003-04-17 2007-05-02 Kowa Co LKLF / KLF2 GEN-EXPRESSIONSPROMOTER
WO2005077916A1 (en) * 2004-01-19 2005-08-25 Ranbaxy Laboratories Limited Salts of hmg-coa reductase inhibitors and use thereof
WO2005053683A1 (en) * 2003-11-26 2005-06-16 Duke University A method of preventing or treating glaucoma
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
CN101220021B (zh) * 2007-01-12 2010-12-08 上海医药工业研究院 4-取代苯氧基喹啉类化合物及其中间体、制备方法和应用
WO2008111055A1 (en) * 2007-03-12 2008-09-18 In-Dot Ltd. Color sensing for a reader device and the like
JP5533654B2 (ja) * 2008-09-05 2014-06-25 日産化学工業株式会社 3,5−ジヒドロキシ−6−ヘプテン酸アミン塩類の製造方法
US20120022102A1 (en) 2010-01-20 2012-01-26 Cadila Healthcare Limited Method for preparation of pitavastatin and its pharmaceutical acceptable salts thereof
JP2013536219A (ja) 2010-08-25 2013-09-19 カディラ・ヘルスケア・リミテッド ピタバスタチンカルシウムおよびその調製方法
EP3178812A1 (en) * 2010-11-12 2017-06-14 Hetero Research Foundation Novel polymorphs of pitavastatin calcium
KR101270586B1 (ko) * 2010-11-26 2013-06-03 주식회사 아미노로직스 광학적으로 순수한 2,2'-디히드록시-1,1'-바이나프틸-3-카르복실산의 제조방법
WO2012140490A2 (en) 2011-04-11 2012-10-18 Aurobindo Pharma Limited Process for preparing quinoline derivative
JP2011173912A (ja) * 2011-04-28 2011-09-08 Ube Industries Ltd (3r,5s)−7−置換−3,5−ジヒドロキシヘプト−6−エン酸の製法
PT2751081T (pt) 2011-09-12 2017-04-04 D O O Farma Grs Forma polimórfica de pitavastatina cálcica
JP2013103884A (ja) * 2011-11-10 2013-05-30 Daito Kk ピタバスタチンカルシウム塩の工業的製造方法
CN102653523A (zh) * 2011-12-17 2012-09-05 东莞达信生物技术有限公司 一种匹伐他汀钙重结晶制取方法
WO2013098773A1 (en) * 2011-12-28 2013-07-04 Dr. Reddy's Laboratories Limited Crystalline forms of pitavastatin calcium
CN102653524A (zh) * 2012-01-12 2012-09-05 东莞达信生物技术有限公司 一种匹伐他汀钙中间体的制备方法
WO2014154856A1 (en) * 2013-03-29 2014-10-02 Dsm Sinochem Pharmaceuticals Netherlands B.V. Amine salts of pravastatin and rosuvastatin
EP2978744A1 (en) * 2013-03-29 2016-02-03 DSM Sinochem Pharmaceuticals Netherlands B.V. Amine salts of pitavastatin and rosuvastatin
CN103508949B (zh) * 2013-10-22 2015-12-09 黄河三角洲京博化工研究院有限公司 一种(e)-3-[2-环丙基-4-(4-氟-苯基)-3-喹啉基]丙烯醛的合成方法
WO2016056658A1 (ja) * 2014-10-10 2016-04-14 株式会社エーピーアイ コーポレーション スタチン系化合物の精製方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH567477A5 (cs) * 1972-03-10 1975-10-15 Ciba Geigy Ag
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
CA1336714C (en) * 1987-08-20 1995-08-15 Yoshihiro Fujikawa Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis
DE3905908A1 (de) 1989-02-25 1990-09-06 Bayer Ag Substituierte chinoline, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
FI94339C (fi) * 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
DE3925636A1 (de) * 1989-08-03 1991-02-07 Bayer Ag Imino-substituierte pyridine
EP0430129A3 (en) * 1989-11-30 1992-02-26 Tanabe Seiyaku Co., Ltd. Novel phenylethylene derivatives, processes for preparing the same and intermediates therefor
JPH054943A (ja) * 1990-08-30 1993-01-14 Sagami Chem Res Center 光学活性β,δ−ジケト酸エステル及びその還元体

Also Published As

Publication number Publication date
CA2072162A1 (en) 1992-12-25
CA2072162C (en) 2002-11-19
US5514804A (en) 1996-05-07
KR930000486A (ko) 1993-01-15
EP0742209A3 (en) 1997-05-14
US5473075A (en) 1995-12-05
KR100208867B1 (ko) 1999-07-15
US5284953A (en) 1994-02-08
EP0742209A2 (en) 1996-11-13
EP0520406A1 (en) 1992-12-30
DE69226822D1 (de) 1998-10-08
EP0520406B1 (en) 1998-09-02
ATE170513T1 (de) 1998-09-15
ES2120973T3 (es) 1998-11-16
TW293007B (cs) 1996-12-11
DE69226822T2 (de) 1999-02-11
JP3528186B2 (ja) 2004-05-17
JPH05148237A (ja) 1993-06-15

Similar Documents

Publication Publication Date Title
DK0520406T3 (da) Diastereomert salt af optisk aktiv quinolinmevalonsyre
NO178969C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte kinazolinoner
DE69325944D1 (de) s-Triazinderivate als Lichtschutzmittel
FI910860A7 (fi) Menetelmä lääkeaineina käyttökelpoisten /2-(1-homopiperatsiinikarbonyyli)pyrrolidin-4-yylitio/-6-(1-hydroksietyyli)-1-karbapen-2-eemi-3-karboksylaattisuolojen valmistamiseksi
DE69327567D1 (de) Verfahren zur Herstellung von Alanylglutamin
ATE72224T1 (de) Verfahren zur optischen spaltung von 2-(6-methoxy-2-naphtyl)propionsaeure.
NO902839L (no) Fremgangsmaate for rensing av tryptofan.
DE69328962D1 (de) Verfahren zur herstellng von cyano-methoxyiminomethylderivaten
FI955498A0 (fi) Nipekotiinihappojohdannaisia hyytymistä estävinä aineina
UA8357A1 (uk) Спосіб оптичного поділу піранобензоксадіазольної сполуки
DE59302245D1 (de) Verfahren zur Herstellung von Distyrylbiphenylverbindungen
DE69018716D1 (de) Verfahren zur optischen Aufspaltung von pyranobenzoxadiazolverbindungen.
PT100159A (pt) Processo para a preparacao de trans-piperidino-2,5-dicarboxilatos
ATE321033T1 (de) Verfahren zur herstellung von substituierten alkylaminen oder salzen davon
IT9022209A0 (it) Processo per la granulazione di sali potessici
ATE103276T1 (de) Verfahren zur herstellung von chinolin-2,3carbons|ure.
DE60001298D1 (de) Verfahren zur Herstellung von Omeprazol
NO175255C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive alkylestere av 2-(4-(2-piperidino-etoksy)-benzoyl)-benzosyre med forgrenet kjede
ES2060854T3 (es) Procedimiento para la preparacion de acido 2-mercapto-4-metil-1,3-tiazol-5-il-acetico y sus esteres.
BR9405262A (pt) Processo para a preparação de um ácido piridina-2,3-dicarboxílico
ES2195309T3 (es) Derivados de tetrahidrofurano.
DK0837066T3 (da) Forbedret fremgangsmåde til fremstilling af penicillin G phenylester
FR2616147B1 (fr) Procede d'obtention de derives d'acides 4-phenoxyphenoxy-alcanecarboxyliques